Found 8 matching trials
Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease) PHASE2 Study to evaluate the safety of combivent delivered in two different formul...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis PHASE3 Study to evaluate the bronchodilator efficacy and safety of a fixed combina...
Show More Location
Multiple Locations
Learn More & Join Trial
Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease PHASE3 The primary objective of this study was to compare the long-term (12-week) ...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness of the Aeroneb in Acute Severe Asthma NA Background: The bronchodilator therapy is an essential component of the man...
Show More Location
Tufts Medical Center
Learn More & Join Trial
A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 Study to demonstrate the comparability of two puffs of Combivent hydrofluor...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients. PHASE4 The objective of this study is to evaluate the efficacy and safety of 12 we...
Show More Location
205.346.107 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 To compare the long-term (one-year) bronchodilator efficacy and safety of C...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. PHASE4 The objective of this study is to evaluate the efficacy and safety of 12 we...
Show More Location
205.325.904 Boehringer Ingelheim Investigational Site
Learn More & Join Trial